Core Extraordinary Items vs Non Operating Income Net Other Analysis

CLB Stock

USD 15.70 0.01 0.06%

Core Laboratories financial indicator trend analysis is way more than just evaluating Core Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Core Laboratories is a good investment. Please check the relationship between Core Laboratories Extraordinary Items and its Non Operating Income Net Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Extraordinary Items vs Non Operating Income Net Other

Extraordinary Items vs Non Operating Income Net Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Core Laboratories Extraordinary Items account and Non Operating Income Net Other. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Core Laboratories' Extraordinary Items and Non Operating Income Net Other is 0.15. Overlapping area represents the amount of variation of Extraordinary Items that can explain the historical movement of Non Operating Income Net Other in the same time period over historical financial statements of Core Laboratories NV, assuming nothing else is changed. The correlation between historical values of Core Laboratories' Extraordinary Items and Non Operating Income Net Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Extraordinary Items of Core Laboratories NV are associated (or correlated) with its Non Operating Income Net Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Operating Income Net Other has no effect on the direction of Extraordinary Items i.e., Core Laboratories' Extraordinary Items and Non Operating Income Net Other go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Extraordinary Items

Non Operating Income Net Other

Most indicators from Core Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Core Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Tax Provision is expected to grow to about 10.8 M, whereas Selling General Administrative is forecasted to decline to about 34.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	83.8M	78.9M	94.0M	171.1M
Total Revenue	470.3M	489.7M	509.8M	619.3M

Gross Profit Total Revenue

Core Laboratories fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.81	0.64	0.86	0.41	0.82	0.8	0.52	0.7	0.54	0.93	-0.21	0.54	0.73	0.54	0.85	0.68	0.75	-0.29	0.9	0.8	0.82	-0.05	0.44	0.84	0.57
Short Long Term Debt Total	0.81		0.64	0.64	-0.16	0.77	1.0	0.36	0.34	0.43	0.81	-0.32	0.43	0.52	0.2	0.99	0.39	0.64	-0.43	0.97	0.72	0.57	-0.12	0.5	0.53	0.51
Other Current Liab	0.64	0.64		0.83	-0.1	0.37	0.61	0.81	0.61	0.74	0.45	0.09	0.74	0.82	0.24	0.68	0.2	0.54	-0.8	0.75	0.33	0.76	-0.7	0.16	0.51	0.53
Total Current Liabilities	0.86	0.64	0.83		0.31	0.52	0.6	0.81	0.91	0.82	0.63	0.06	0.82	0.93	0.57	0.68	0.56	0.77	-0.6	0.79	0.47	0.96	-0.31	0.21	0.8	0.66
Total Stockholder Equity	0.41	-0.16	-0.1	0.31		0.31	-0.17	0.13	0.52	0.09	0.36	0.01	0.09	0.28	0.67	-0.11	0.66	0.18	0.33	-0.02	0.36	0.37	0.34	0.03	0.57	0.1
Property Plant And Equipment Net	0.82	0.77	0.37	0.52	0.31		0.77	0.08	0.3	0.26	0.91	-0.57	0.26	0.32	0.5	0.77	0.65	0.49	0.04	0.76	0.99	0.45	0.24	0.32	0.69	0.43
Net Debt	0.8	1.0	0.61	0.6	-0.17	0.77		0.31	0.3	0.38	0.82	-0.36	0.38	0.48	0.19	0.99	0.37	0.62	-0.4	0.96	0.73	0.53	-0.11	0.54	0.5	0.51
Retained Earnings	0.52	0.36	0.81	0.81	0.13	0.08	0.31		0.77	0.75	0.21	0.39	0.75	0.94	0.28	0.38	0.23	0.55	-0.84	0.5	0.05	0.86	-0.54	0.17	0.43	0.4
Accounts Payable	0.7	0.34	0.61	0.91	0.52	0.3	0.3	0.77		0.76	0.44	0.19	0.76	0.89	0.66	0.39	0.6	0.69	-0.47	0.52	0.27	0.92	-0.22	0.07	0.75	0.58
Cash	0.54	0.43	0.74	0.82	0.09	0.26	0.38	0.75	0.76		0.26	0.25	1.0	0.81	0.56	0.44	0.44	0.48	-0.67	0.55	0.24	0.82	-0.36	-0.11	0.67	0.56
Non Current Assets Total	0.93	0.81	0.45	0.63	0.36	0.91	0.82	0.21	0.44	0.26		-0.43	0.26	0.45	0.42	0.85	0.59	0.62	-0.04	0.85	0.88	0.55	0.08	0.53	0.71	0.51
Non Currrent Assets Other	-0.21	-0.32	0.09	0.06	0.01	-0.57	-0.36	0.39	0.19	0.25	-0.43		0.25	0.3	-0.16	-0.33	-0.01	-0.24	-0.23	-0.27	-0.49	0.21	-0.3	-0.33	0.04	-0.48
Cash And Short Term Investments	0.54	0.43	0.74	0.82	0.09	0.26	0.38	0.75	0.76	1.0	0.26	0.25		0.81	0.56	0.44	0.44	0.48	-0.67	0.55	0.24	0.82	-0.36	-0.11	0.67	0.56
Net Receivables	0.73	0.52	0.82	0.93	0.28	0.32	0.48	0.94	0.89	0.81	0.45	0.3	0.81		0.47	0.55	0.48	0.67	-0.72	0.66	0.3	0.97	-0.41	0.2	0.67	0.48
Common Stock Shares Outstanding	0.54	0.2	0.24	0.57	0.67	0.5	0.19	0.28	0.66	0.56	0.42	-0.16	0.56	0.47		0.23	0.78	0.39	-0.1	0.31	0.54	0.57	0.17	-0.07	0.77	0.55
Non Current Liabilities Total	0.85	0.99	0.68	0.68	-0.11	0.77	0.99	0.38	0.39	0.44	0.85	-0.33	0.44	0.55	0.23		0.38	0.68	-0.44	0.99	0.72	0.6	-0.19	0.53	0.56	0.57
Inventory	0.68	0.39	0.2	0.56	0.66	0.65	0.37	0.23	0.6	0.44	0.59	-0.01	0.44	0.48	0.78	0.38		0.35	0.07	0.44	0.72	0.64	0.34	-0.03	0.86	0.18
Other Current Assets	0.75	0.64	0.54	0.77	0.18	0.49	0.62	0.55	0.69	0.48	0.62	-0.24	0.48	0.67	0.39	0.68	0.35		-0.43	0.74	0.41	0.73	-0.05	0.31	0.54	0.68
Other Stockholder Equity	-0.29	-0.43	-0.8	-0.6	0.33	0.04	-0.4	-0.84	-0.47	-0.67	-0.04	-0.23	-0.67	-0.72	-0.1	-0.44	0.07	-0.43		-0.5	0.09	-0.6	0.7	-0.24	-0.12	-0.48
Total Liab	0.9	0.97	0.75	0.79	-0.02	0.76	0.96	0.5	0.52	0.55	0.85	-0.27	0.55	0.66	0.31	0.99	0.44	0.74	-0.5		0.71	0.71	-0.23	0.49	0.64	0.62
Property Plant And Equipment Gross	0.8	0.72	0.33	0.47	0.36	0.99	0.73	0.05	0.27	0.24	0.88	-0.49	0.24	0.3	0.54	0.72	0.72	0.41	0.09	0.71		0.44	0.27	0.26	0.72	0.33
Total Current Assets	0.82	0.57	0.76	0.96	0.37	0.45	0.53	0.86	0.92	0.82	0.55	0.21	0.82	0.97	0.57	0.6	0.64	0.73	-0.6	0.71	0.44		-0.24	0.15	0.79	0.5
Short Term Debt	-0.05	-0.12	-0.7	-0.31	0.34	0.24	-0.11	-0.54	-0.22	-0.36	0.08	-0.3	-0.36	-0.41	0.17	-0.19	0.34	-0.05	0.7	-0.23	0.27	-0.24		-0.05	0.04	-0.26
Intangible Assets	0.44	0.5	0.16	0.21	0.03	0.32	0.54	0.17	0.07	-0.11	0.53	-0.33	-0.11	0.2	-0.07	0.53	-0.03	0.31	-0.24	0.49	0.26	0.15	-0.05		-0.04	0.37
Common Stock Total Equity	0.84	0.53	0.51	0.8	0.57	0.69	0.5	0.43	0.75	0.67	0.71	0.04	0.67	0.67	0.77	0.56	0.86	0.54	-0.12	0.64	0.72	0.79	0.04	-0.04		0.42
Common Stock	0.57	0.51	0.53	0.66	0.1	0.43	0.51	0.4	0.58	0.56	0.51	-0.48	0.56	0.48	0.55	0.57	0.18	0.68	-0.48	0.62	0.33	0.5	-0.26	0.37	0.42

Click cells to compare fundamentals

Core Laboratories Account Relationship Matchups

Core Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Short Long Term Debt Total	381.8M	327.0M	250.3M	222.4M	215.4M	217.2M
Other Current Liab	50.8M	49.8M	40.9M	39.6M	39.7M	47.9M
Total Current Liabilities	111.6M	89.8M	90.8M	103.1M	88.1M	100.6M
Total Stockholder Equity	182.1M	75.6M	161.0M	189.0M	224.8M	131.8M
Property Plant And Equipment Net	199.2M	181.7M	172.3M	157.4M	153.5M	120.1M
Net Debt	370.7M	313.2M	232.6M	207.0M	200.3M	187.0M
Retained Earnings	160.5M	50.5M	68.3M	85.9M	120.8M	194.2M
Accounts Payable	35.6M	23.0M	29.7M	45.8M	33.5M	35.9M
Cash	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Non Current Assets Total	553.4M	402.7M	391.8M	366.7M	363.3M	325.2M
Non Currrent Assets Other	(71.3M)	(76.9M)	(74.6M)	(73.0M)	29.4M	30.8M
Cash And Short Term Investments	11.1M	13.8M	17.7M	15.4M	15.1M	14.4M
Net Receivables	131.6M	83.2M	96.8M	106.9M	123.1M	129.1M
Common Stock Shares Outstanding	44.6M	45.0M	46.7M	46.8M	47.5M	40.8M
Liabilities And Stockholders Equity	774.7M	568.6M	580.9M	578.4M	586.4M	550.2M
Non Current Liabilities Total	480.9M	403.3M	329.1M	286.3M	268.5M	267.2M
Inventory	50.2M	38.2M	45.4M	60.4M	71.7M	39.7M
Other Current Assets	28.4M	30.7M	29.1M	28.9M	13.2M	26.0M
Other Stockholder Equity	26.8M	31.2M	101.6M	105.6M	108.6M	114.0M
Total Liab	592.5M	493.0M	419.9M	389.4M	356.6M	367.8M
Property Plant And Equipment Gross	199.2M	181.7M	172.3M	157.4M	181.0M	118.3M
Total Current Assets	221.2M	165.8M	189.1M	211.7M	223.1M	225.0M
Accumulated Other Comprehensive Income	(6.3M)	(7.2M)	(10.1M)	(3.8M)	(5.0M)	(5.2M)
Short Term Debt	11.8M	11.4M	12.3M	11.7M	10.2M	8.7M
Intangible Assets	17.5M	8.6M	8.1M	7.5M	6.9M	6.6M
Other Liab	109.9M	87.7M	91.1M	75.6M	86.9M	66.4M
Other Assets	119.4M	179.4M	107.7M	102.3M	1.0	0.95
Long Term Debt	305.3M	259.4M	188.6M	172.4M	198.2M	229.8M
Property Plant Equipment	123.5M	115.3M	172.3M	157.4M	181.0M	126.1M
Current Deferred Revenue	13.4M	5.5M	7.8M	5.9M	4.8M	4.5M
Treasury Stock	(29.4M)	(14.1M)	(4.1M)	(1.4M)	(1.6M)	(1.6M)
Net Tangible Assets	11.7M	19.6M	(58.5M)	115.6M	104.1M	109.3M
Noncontrolling Interest In Consolidated Entity	4.3M	4.1M	4.6M	4.7M	5.4M	4.6M
Retained Earnings Total Equity	160.5M	50.5M	68.3M	85.9M	77.4M	73.5M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Core Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Core Laboratories' short interest history, or implied volatility extrapolated from Core Laboratories options trading.

Pair Trading with Core Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Core Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Core Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving together with Core Stock

0.93	NR	Newpark Resources Financial Report 7th of May 2024	Pair Corr
0.74	TS	Tenaris SA ADR	Pair Corr
0.65	DNOW	Now Inc Earnings Call Next Week	Pair Corr

Moving against Core Stock

0.56

NOA

North American Const

Pair Corr

The ability to find closely correlated positions to Core Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Core Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Core Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Core Laboratories NV to buy it.

The correlation of Core Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Core Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Core Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Core Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core

Details

Is Core Stock a good investment?

Details

What is Core Laboratories' Net Worth?

Details

Largest Oil & Gas Equipment & Services Companies

View

Largest Energy Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.

	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.374

Dividend Share

0.04

Earnings Share

0.51

Revenue Per Share

10.935

Quarterly Revenue Growth

0.01

The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Core Extraordinary Items vs Non Operating Income Net Other Analysis

Extraordinary Items vs Non Operating Income Net Other

Extraordinary Items vs Non Operating Income Net Other Correlation Analysis

Correlation Coefficient

Extraordinary Items

Non Operating Income Net Other

Core Laboratories fundamental ratios Correlations

Core Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Core Laboratories fundamental ratios Accounts

Pair Trading with Core Laboratories

Moving together with Core Stock

Moving against Core Stock

Complementary Tools for Core Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.99	Net Debt
Total Liab	+ 0.99	Non Current Liabilities Total

Other Stockholder Equity	- 0.84	Retained Earnings
Other Stockholder Equity	- 0.8	Other Current Liab
Other Stockholder Equity	- 0.72	Net Receivables
Short Term Debt	- 0.7	Other Current Liab
Other Stockholder Equity	- 0.67	Cash And Short Term Investments
Other Stockholder Equity	- 0.67	Cash